SCOPUS 정보 검색 플랫폼

Cerebrovascular Diseases

Volumn 10, Issue 6, 2000, Pages 431-436

Phase II clinical trial of sipatrigine (619C89) by continuous infusion in acute stroke

(3) Muir, Keith W a,c Holzapfel, Laurent b Lees, Kennedy R a

a WESTERN INFIRMARY (United Kingdom)

b Emergency Department (France)

c SOUTHERN GENERAL HOSPITAL (United Kingdom)

Author keywords

Clinical trial, sipatrigine; Excitatory amino acid; Glutamate; Neuroprotection; Sodium channel; Stroke drug treatment

Indexed keywords

PLACEBO; SIPATRIGINE; SODIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

AGED; AGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; HALLUCINATION; HUMAN; HYPONATREMIA; MULTICENTER STUDY; NAUSEA; NEUROPROTECTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; VISUAL DISORDER; VOMITING;

EID: 0033777534 PISSN: 10159770 EISSN: None Source Type: Journal
DOI: 10.1159/000016103 Document Type: Article

Times cited : (60)

References (13)

1
- 0027495382
- AMPA antagonists: Do they hold more promise for clinical stroke trials than NMDA antagonists?
- (1993) Stroke , vol.24 , Issue.SUPPL. 1 , pp. 148-152
- Buchan, A.M.¹ Lesiuk, H.² Barnes, K.A.³ Li, H.⁴ Huang, Z.G.⁵ Smith, K.E.⁶ Xue, D.⁷

2
- 0027152254
- Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemia
- (1993) Prog Brain Res , vol.96 , pp. 125-135
- Pulsinelli, W.¹ Sarokin, A.² Buchan, A.³

3
- 0027427180
- Pharmacological modification of glutamate neurotoxicity in vivo
- (1993) Brain Res , vol.629 , pp. 73-78
- Fujisawa, H.¹ Dawson, D.² Browne, S.E.³ MacKay, K.B.⁴ Bullock, R.⁵ McCulloch, J.⁶

4
- 0028362182
- Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion
- (1994) J Pharmacol Exp Ther , vol.269 , pp. 854-859
- Graham, S.H.¹ Chen, J.² Lan, J.³ Leach, M.J.⁴ Simon, R.P.⁵

5
- 0027421635
- Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat
- (1993) Neuroreport , vol.4 , pp. 1339-1342
- Smith, S.E.¹ Lekieffre, D.² Sowinski, P.³ Meldrum, B.S.⁴

6
- 0027287896
- BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage
- (1993) Stroke , vol.24 , pp. 1063-1067
- Leach, M.J.¹ Swan, J.H.² Eisenthal, D.³ Dopson, M.⁴ Nobbs, M.⁵

7
- 0029552523
- The tolerability, pharmacokinetics and pharmacodynamics of increasing intravenous doses of 619C89, a novel compound for the acute treatment of stroke, in healthy volunteers
- (1995) Ann NY Acad Sci , vol.765 , pp. 324-326
- Mercer, A.J.¹ Lamb, R.J.² Hussein, Z.³ Hobbiger, S.⁴ Posner, J.⁵

8
- 0029887359
- Pharmacokinetics of 619C89, a novel neuronal sodium channel inhibitor, in acute stroke patients after loading and discrete maintenance infusions
- (1996) Br J Clin Pharmacol , vol.41 , pp. 505-511
- Hussein, Z.¹ Fraser, I.J.² Lees, K.R.³ Muir, K.W.⁴ Lunnon, M.W.⁵ Hobbiger, S.F.⁶ Posner, J.⁷

9
- 0031963673
- Safety and tolerability of 619C89 after acute stroke
- (1998) Cerebrovasc Dis , vol.8 , pp. 31-37
- Muir, K.W.¹ Hamilton, S.J.C.² Lunnon, M.W.³ Hobbiger, S.⁴ Lees, K.R.⁵

10
- 0024328055
- Measurements of acute cerebral infarction. A clinical examination scale
- (1989) Stroke , vol.20 , pp. 864-870
- Brott, T.¹ Adams H.P., Jr.² Olinger, C.P.³ Marler, J.R.⁴ Barsan, W.G.⁵ Biller, J.⁶ Spilker, J.⁷ Holleran, R.⁸ Eberle, R.⁹ Hertzberg, V.¹⁰ Rorick, M.¹¹ Moomaw, C.J.¹² Walker, M.¹³

11
- 70449137214
- Cerebral vascular accidents in patients over the age of 60. 2. Prognosis
- (1957) Scott Med J , vol.2 , pp. 200-215
- Rankin, J.¹

12
- 70450195021
- Functional evaluation: The Barthel index
- (1965) Md State Med J , vol.14 , pp. 61-65
- Mahoney, F.I.¹ Barthel, D.W.²

13
- 0025739901
- Classification and natural history of clinically identifiable subtypes of cerebral infarction
- (1991) Lancet , vol.337 , pp. 1521-1526
- Bamford, J.¹ Sandercock, P.² Dennis, M.³ Burn, J.⁴ Warlow, C.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.